Posted by Michael Wonder on 06 May 2020
COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians
6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first countries in the world to start production of a potentially lifesaving plasma-derived treatment for people with COVID-19.
The product, COVID-19 immunoglobulin, could be used to treat people seriously ill with complications caused by the virus, particularly those whose illness is progressing towards the need for ventilation.
Victoria is host to one of the first facilities in the world to start production of COVID-19 immunoglobulin, supporting clinical trials of the treatment in Australia which will support Australians with COVID-19.
